Rewire AI

About:

Rewire AI provides an adaptive AI-as-a-Service platform for integrated computer vision for diagnostic device and microscope partners.

Website: https://rewire.ai

Twitter/X: RewireAI

Top Investors: Washington State University, Elevate Capital, National Institute of General Medical Science, Business Oregon, Angel Oregon Tech 2021

Description:

Rewire AI's purpose is to accelerate human efficiency in healthcare. Our AI-as-a-Service platform provides integrated machine learning to enterprise diagnostic device partners, which improves speed, accuracy, and cost of biomedical imaging. Rewire‘s ML platform, called Sightologist.ai, integrates highly-accurate computer vision into clinical devices, microscopes, and software to automatically detect and quantify protein and cellular biomarkers.

Total Funding Amount:

$2.92M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Portland, Oregon, United States

Founded Date:

2020-07-24

Contact Email:

us(AT)rewire.ai

Founders:

John Harkness

Number of Employees:

1-10

Last Funding Date:

2023-08-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai